Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension refers to high blood pressure in arteries of the lung. The underlying cause include blood clots and related scarring. Discover the latest research on this disease here.

August 19, 2020

CT-Based Biomarkers for Prediction of Chronic Thromboembolic Pulmonary Hypertension After an Acute Pulmonary Embolic Event

AJR. American Journal of Roentgenology
Giovanni LorenzRahul D Renapurkar
September 10, 2020

Galectin-3, GDF-15, and sST2 for the Assessment of Disease Severity and Therapy Response in patients suffering from inoperable Chronic Thromboembolic Pulmonary Hypertension

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Steffen D KriechbaumChristoph Liebetrau
August 24, 2020
Open Access

Treatment-related Biomarkers in Pulmonary Hypertension Patients on Oral Therapies

Aparna C SwaminathanTim McMahon
August 4, 2020
Open Access

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: State of the art

World Journal of Clinical Cases
Qi JinZhi-Hong Liu
August 31, 2020
Open Access

Pulmonary Hypertension: A Brief Guide for Clinicians

Mayo Clinic Proceedings
Stacy A MandrasAnjali Vaidya
August 31, 2020
Open Access

Pulmonary thromboendarterectomy in Portugal: Initial experience

Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
José Fragata, Helena Telles
August 28, 2020
Case Report
Open Access

Chronic Thromboembolic Pulmonary Hypertension in a Child With Sickle Cell Disease

Frontiers in Pediatrics
Robert SpencerErika B Rosenzweig
September 18, 2020

A rare case of cardiac mass complicated with chronic thromboembolic pulmonary hypertension

Journal of Cardiac Surgery
Xiaoli QinZhong Wu
July 30, 2020
Open Access

Use of Anticoagulants in Patients with Pulmonary Hypertension

L BertolettiGeorge Giannakoulas
August 26, 2020
Open Access

Antiphospholipid syndrome with chronic thromboembolic pulmonary hypertension and coronary artery disease: a case report

Journal of Cardiothoracic Surgery
Kayo SugiyamaHitoshi Ogino
August 2, 2020

The evolving role of interventional cardiology in the treatment of pulmonary hypertension

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
Sergery Gurevich, Kurt W Prins
August 31, 2020
Open Access

Essential aspects of the follow-up after acute pulmonary embolism: An illustrated review

Research and Practice in Thrombosis and Haemostasis
Gudula J A M BoonFrederikus A Klok
September 26, 2020

Clinical Characteristics and Etiological Analysis of 133 Patients for Pulmonary Embolism Combined with Hemoptysis

The Clinical Respiratory Journal
YongWei ZouHong Chen
August 8, 2020

How I Do It: The PERT Concept: A Step-by-Step Approach to Managing PE

Belinda N Rivera-LebronVictor F Tapson

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved